Cohance Lifesciences Ltd

NSE: COHANCE · BSE: 543064 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹455.45
Market cap: ₹17,425 Cr
Revenue (annual): ₹2,269 Cr
Net profit (annual): ₹179.2 Cr
P/E (TTM): 164.0×Sector 47.3×
Promoter holding: 57.49%+0.00% QoQ
FII holding: 6.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Business Update 4 Earnings Call 2 Annual General Meeting 2 Results Update 1 Results Correction 1 Merger & Restructuring 1 Financial Results 1 Employee Stock Options 1 Credit Rating 1 Capital Structure Change 1 Board Meeting Date 1 Annual Report 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

23 Jul 2026 21:27 IST BSE

Employee Stock Options

Cohance Lifesciences Employee Stock Options

Cohance Lifesciences granted employee stock options under ESOP 2026 and ESOP 2023, while also allotting equity shares upon the exercise of vested options.

Read the filing ↗